Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -464.86% is 114% below its 5-year average of -216.87%, near the high end of its 5-year range (-4386.10%–-79.36%).
As of the fiscal period ended Tuesday, March 31, 2026. 61.12% above its 12-month average of -1195.61%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -464.86%.
RETURN ON INVESTED CAPITAL (ROIC)
-464.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1195.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-178.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-216.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+61.12%
CURRENT VS 3Y AVG
-159.74%
CURRENT VS 5Y AVG
-114.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
-1282.88%
vs the sector median at left
BioRestorative Therapies, Inc.
Market Cap
$3.07M
Return on Invested Capital (ROIC)
-464.86%
TTM Avg
-1195.61%
3Y Avg
-178.97%
5Y Avg
-216.87%
Market Cap
$3.12M
Return on Invested Capital (ROIC)
-104.28%
TTM Avg
-131.89%
3Y Avg
-356.58%
5Y Avg
-286.34%
Market Cap
$2.99M
Return on Invested Capital (ROIC)
-75.31%
TTM Avg
-107.77%
3Y Avg
-224.28%
5Y Avg
-195.58%
Market Cap
$3.17M
Return on Invested Capital (ROIC)
-69.04%
TTM Avg
-69.04%
3Y Avg
-66.04%
5Y Avg
-57.92%
Market Cap
$3.18M
Return on Invested Capital (ROIC)
-184.27%
TTM Avg
-194.39%
3Y Avg
-144.44%
5Y Avg
-112.27%
Market Cap
$3.25M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
Market Cap
$3.29M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
Market Cap
$3.35M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.37M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.07M | -464.86% | -1195.61% | -178.97% | -216.87% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | -104.28% | -131.89% | -356.58% | -286.34% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.99M | -75.31% | -107.77% | -224.28% | -195.58% |
| MBody AI Ltd. (MBAI)vs › | $3.17M | -69.04% | -69.04% | -66.04% | -57.92% |
| IceCure Medical Ltd (ICCM)vs › | $3.18M | -184.27% | -194.39% | -144.44% | -112.27% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -9.72% | -8.51% | -19.00% | -22.23% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | -133.29% | -160.18% | -147.91% | -122.63% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.35M | -284.81% | -319.42% | -246.02% | -246.02% |
| Moolec Science S.A. (MLEC)vs › | $3.37M | -33.50% | -18.16% | -45.78% | -36.63% |
| Eocene Ltd. (EOCN)vs › | $3.46M | N/A | N/A | N/A | N/A |
ROIC
-464.9%
ROE
-365.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | -464.86% |
| 2025-12-31 | -4386.10% |
| 2025-09-30 | -657.55% |
| 2025-06-30 | -270.16% |
| 2025-03-31 | -199.41% |
| 2024-12-31 | -135.44% |
| 2024-09-30 | -120.96% |
| 2024-06-30 | -119.48% |
| 2024-03-31 | -93.43% |
| 2023-12-31 | -149.71% |
| 2023-09-30 | -128.08% |
| 2023-06-30 | -143.91% |
| 2023-03-31 | -143.21% |
| 2022-12-31 | -181.52% |
| 2022-09-30 | -105.56% |
| 2022-06-30 | -91.72% |
| 2022-03-31 | -79.36% |
| 2021-12-31 | -118.78% |
| 2021-09-30 | -1720.45% |
| 2021-06-30 | -1264.27% |
| 2021-03-31 | -700.48% |
| 2020-12-31 | -83.13% |
| 2020-09-30 | -346.12% |
| 2020-06-30 | -363.65% |
